Literature DB >> 22592672

Speech and language therapy for aphasia following stroke.

Marian C Brady1, Helen Kelly, Jon Godwin, Pam Enderby.   

Abstract

BACKGROUND: Aphasia is an acquired language impairment following brain damage that affects some or all language modalities: expression and understanding of speech, reading and writing. Approximately one-third of people who have a stroke experience aphasia.
OBJECTIVES: To assess the effectiveness of speech and language therapy (SLT) for aphasia following stroke. SEARCH
METHODS: We searched the Cochrane Stroke Group Trials Register (last searched June 2011), MEDLINE (1966 to July 2011) and CINAHL (1982 to July 2011). In an effort to identify further published, unpublished and ongoing trials we handsearched the International Journal of Language and Communication Disorders (1969 to 2005) and reference lists of relevant articles and contacted academic institutions and other researchers. There were no language restrictions. SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing SLT (a formal intervention that aims to improve language and communication abilities, activity and participation) with (1) no SLT; (2) social support or stimulation (an intervention that provides social support and communication stimulation but does not include targeted therapeutic interventions); and (3) another SLT intervention (which differed in duration, intensity, frequency, intervention methodology or theoretical approach). DATA COLLECTION AND ANALYSIS: We independently extracted the data and assessed the quality of included trials. We sought missing data from investigators. MAIN
RESULTS: We included 39 RCTs (51 randomised comparisons) involving 2518 participants in this review. Nineteen randomised comparisons (1414 participants) compared SLT with no SLT where SLT resulted in significant benefits to patients' functional communication (standardised mean difference (SMD) 0.30, 95% CI 0.08 to 0.52, P = 0.008), receptive and expressive language. Seven randomised comparisons (432 participants) compared SLT with social support and stimulation but found no evidence of a difference in functional communication. Twenty-five randomised comparisons (910 participants) compared two approaches to SLT. There was no indication of a difference in functional communication. Generally, the trials randomised small numbers of participants across a range of characteristics (age, time since stroke and severity profiles), interventions and outcomes. Suitable statistical data were unavailable for several measures. AUTHORS'
CONCLUSIONS: Our review provides some evidence of the effectiveness of SLT for people with aphasia following stroke in terms of improved functional communication, receptive and expressive language. However, some trials were poorly reported. The potential benefits of intensive SLT over conventional SLT were confounded by a significantly higher dropout from intensive SLT. More participants also withdrew from social support than SLT interventions. There was insufficient evidence to draw any conclusion regarding the effectiveness of any one specific SLT approach over another.

Entities:  

Mesh:

Year:  2012        PMID: 22592672     DOI: 10.1002/14651858.CD000425.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  73 in total

Review 1.  Brain Stimulation and the Role of the Right Hemisphere in Aphasia Recovery.

Authors:  Peter E Turkeltaub
Journal:  Curr Neurol Neurosci Rep       Date:  2015-11       Impact factor: 5.081

2.  Ultrasonic vocalization changes and FOXP2 expression after experimental stroke.

Authors:  Sarah J Doran; Cassandra Trammel; Sharon E Benashaski; Venugopal Reddy Venna; Louise D McCullough
Journal:  Behav Brain Res       Date:  2015-01-31       Impact factor: 3.332

3.  Success of Anomia Treatment in Aphasia Is Associated With Preserved Architecture of Global and Left Temporal Lobe Structural Networks.

Authors:  Leonardo Bonilha; Ezequiel Gleichgerrcht; Travis Nesland; Chris Rorden; Julius Fridriksson
Journal:  Neurorehabil Neural Repair       Date:  2015-07-06       Impact factor: 3.919

4.  Long-term evaluation of cognition after glioma surgery in eloquent areas.

Authors:  Djaina Satoer; Evy Visch-Brink; Marion Smits; Alfred Kloet; Caspar Looman; Clemens Dirven; Arnaud Vincent
Journal:  J Neurooncol       Date:  2013-10-31       Impact factor: 4.130

5.  Assessment Fidelity in Aphasia Research.

Authors:  Jessica D Richardson; Sarah Grace Hudspeth Dalton; Jennifer Shafer; Janet Patterson
Journal:  Am J Speech Lang Pathol       Date:  2016-12-01       Impact factor: 2.408

6.  Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.

Authors:  Rebecca Palmer; Munyaradzi Dimairo; Nicholas Latimer; Elizabeth Cross; Marian Brady; Pam Enderby; Audrey Bowen; Steven Julious; Madeleine Harrison; Abualbishr Alshreef; Ellen Bradley; Arjun Bhadhuri; Tim Chater; Helen Hughes; Helen Witts; Esther Herbert; Cindy Cooper
Journal:  Health Technol Assess       Date:  2020-04       Impact factor: 4.014

7.  Clarification of conclusions from the ACT NoW trial.

Authors:  Audrey Bowen; Anne Hesketh; Emma Patchick; Alys Young; Linda Davies; Andy Vail; Andrew F Long; Caroline Watkins; Mo Wilkinson; Gill Pearl; Matthew A Lambon Ralph; Pippa Tyrrell; Peter Langhorne
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

Review 8.  [Non-invasive brain stimulation in neurology : Transcranial direct current stimulation to enhance cognitive functioning].

Authors:  D Antonenko; A Flöel
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

9.  The impact of dose on naming accuracy with persons with aphasia.

Authors:  Catherine A Off; Jenna R Griffin; Kristie A Spencer; Margaret Rogers
Journal:  Aphasiology       Date:  2016-10-16       Impact factor: 2.773

Review 10.  New evidence for therapies in stroke rehabilitation.

Authors:  Bruce H Dobkin; Andrew Dorsch
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.